The role of interleukin-10 promoter polymorphisms in primary Sjögren's syndrome

Objective: To determine the impact of a broad spectrum of different polymorphisms within the interleukin-10 (IL-10) promoter gene on disease susceptibility to primary Sjögren's syndrome (pSS), clinical manifestations, and autoantibody production. Methods: We genotyped 111 unrelated German Cauca...

Full description

Saved in:
Bibliographic Details
Published inScandinavian journal of rheumatology Vol. 37; no. 4; pp. 293 - 299
Main Authors Willeke, P., Gaubitz, M., Schotte, H., Becker, H., Domschke, W., Schlüter, B.
Format Journal Article
LanguageEnglish
Published Colchester Informa UK Ltd 01.01.2008
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: To determine the impact of a broad spectrum of different polymorphisms within the interleukin-10 (IL-10) promoter gene on disease susceptibility to primary Sjögren's syndrome (pSS), clinical manifestations, and autoantibody production. Methods: We genotyped 111 unrelated German Caucasian patients with pSS and 145 healthy controls for the single nucleotide polymorphisms (SNPs) at positions −2849, −2776, −2769, −2763, −1349, −1082, −851, −819, −657, and −592 and for the microsatellites IL10.R and IL10.G. Allele and haplotype distributions were compared between patients and controls and between subgroups of patients with different clinical and laboratory findings. Results: We found no significant differences in the allele or haplotype frequencies between pSS patients and healthy controls. After Bonferroni correction we found a significant association of the ACC haplotype (at the −1082, −819, and −592 loci) with immunoglobulin (Ig)A antibodies to anti- -fodrin. Conclusion: Overall we found no associations of IL-10 promoter polymorphisms with the susceptibility to pSS in our cohort. The finding that the production of IgA anti- -fodrin antibodies is associated with polymorphisms within the IL-10 promoter region suggests a genetic contribution to the generation of these antibodies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0300-9742
1502-7732
DOI:10.1080/03009740801910353